Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Perrone

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancerS Cavalieri, F Perrone, R Miceli, et al.
Scientific Reports|June 7, 2024
Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenuesA Busico, P Gasparini, E Rausa, et al.
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
British Journal of Cancer|May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancerM Di Maio, C Gridelli, C Gallo, et al.
British Journal of Cancer|October 14, 2005
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III studyS De Placido, M Lopez, C Carlomagno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationF Morano, S Corallo, M Niger, et al.
ESMO Open|January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancersS Alfieri, S Rota, R Romanò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control studyC Cremolini, F Morano, R Moretto, et al.
ESMO Open|October 30, 2025
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world studyE Colombo, S Cavalieri, A Vingiani, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|May 8, 2018
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancerS Cavalieri, F Perrone, R Miceli, et al.
Scientific Reports|June 7, 2024
Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenuesA Busico, P Gasparini, E Rausa, et al.
ESMO Open|April 16, 2024
ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerP M Carrera, G Curigliano, D Santini, et al.
European Journal of Cancer (Oxford, England : 1990)|November 9, 2016
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impactL D Locati, F Perrone, B Cortelazzi, et al.
British Journal of Cancer|May 27, 2004
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancerM Di Maio, C Gridelli, C Gallo, et al.
British Journal of Cancer|October 14, 2005
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III studyS De Placido, M Lopez, C Carlomagno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationF Morano, S Corallo, M Niger, et al.
ESMO Open|January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancersS Alfieri, S Rota, R Romanò, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control studyC Cremolini, F Morano, R Moretto, et al.
ESMO Open|October 30, 2025
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world studyE Colombo, S Cavalieri, A Vingiani, et al.
Pageof 19